Case report: Favipiravir-induced bluish corneal discoloration in infant with COVID-19

The efficacy and adverse effects of favipiravir on patients with COVID-19: A systematic review and meta-analysis of published clinical trials and observational studies

(2022) Dang The Hung et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

A systematic review and meta-analysis of the epidemiological characteristics of COVID-19 in children

(2022) Fardis Vosoughi et al.   BMC Pediatrics

Favipiravir in Patients With Early Mild-to-moderate Coronavirus Disease 2019 (COVID-19): A Randomized Controlled Trial

(2022) Yoav Golan et al.   CLINICAL INFECTIOUS DISEASES

Favipiravir for symptomatic COVID-19: A nationwide observational cohort study

(2022) Yohei Doi et al.   JOURNAL OF INFECTION AND CHEMOTHERAPY

Bioactive natural products in COVID-19 therapy

(2022) Zhonglei Wang et al.   Frontiers in Pharmacology

Oral GS-441524 derivatives: Next-generation inhibitors of SARS‐CoV‐2 RNA‐dependent RNA polymerase

(2022) Zhonglei Wang et al.   Frontiers in Immunology

Fluorescence of nails and hair on Wood's lamp examination in Covid pandemic; undefined effect of Favipiravir in humans

(2021) Melek Aslan Kayıran et al.   Dermatologic Therapy

Chinese herbal medicine: Fighting SARS-CoV-2 infection on all fronts

(2021) Zhonglei Wang et al.   JOURNAL OF ETHNOPHARMACOLOGY

Fluorescence of ocular surface in a Covid -19 patient after Favipiravir treatment: a case report

(2021) Mehmet Ali Doran et al.   Virology Journal

Natural Products, Alone or in Combination with FDA-Approved Drugs, to Treat COVID-19 and Lung Cancer

(2021) Liyan Yang et al.   Biomedicines

Broad‐spectrum prodrugs with anti‐SARS‐CoV‐2 activities: Strategies, benefits, and challenges

(2021) Zhonglei Wang et al.   JOURNAL OF MEDICAL VIROLOGY

Favipiravir, an anti-influenza drug against life-threatening RNA virus infections

(2020) Kimiyasu Shiraki et al.   PHARMACOLOGY & THERAPEUTICS

Experimental design approach for development of spectrofluorimetric method for determination of favipiravir; a potential therapeutic agent against COVID-19 virus: Application to spiked human plasma

(2020) Safa M. Megahed et al.   SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY